4D Path is a biotechnology company at the forefront of revolutionizing pathology through its patented AI-powered precision diagnostics platform. Their core mission is to enhance cancer diagnosis by providing faster, more accurate, and comprehensive insights from tissue samples. By analyzing quantitative histomorphometric and multiplex immunofluorescence data, 4D Path's technology aims to uncover novel disease biomarkers and therapeutic targets, ultimately improving patient outcomes and streamlining the diagnostic workflow for pathologists and oncologists.
The Cambridge headquarters serves as the central nexus for 4D Path's research and development, AI algorithm development, corporate strategy, business development, and administrative operations.
Situated in the Kendall Square area, known for its dense concentration of biotech companies and research institutions like MIT. The office likely features modern lab spaces and collaborative work environments.
The work culture at 4D Path is expected to be highly innovative, research-intensive, and collaborative, driven by a shared mission to transform cancer diagnostics. It likely encourages interdisciplinary teamwork between scientists, engineers, and medical professionals.
Its Cambridge location provides unparalleled access to a rich ecosystem of academic research, clinical partners, venture capital, and a highly skilled talent pool specializing in biotech, AI, and life sciences.
While headquartered in the United States, 4D Path's impact and collaborations aim to be global. Their AI-powered pathology solutions have the potential to be adopted by healthcare systems and research institutions worldwide. The company actively seeks partnerships and collaborations that can extend the reach of its technology to improve cancer diagnostics on an international scale. Their research contributions and potential future commercialization efforts are not limited by geography.
700 Main Street, Suite 301
Cambridge
MA
USA
Address: Currently, 4D Path's primary operational base appears to be its Cambridge headquarters. Specific details on other distinct office locations are not widely publicized.
Focus remains on the Cambridge HQ for core R&D and corporate functions. Expansion to other locations would likely be driven by strategic partnerships or market access needs.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, 4D Path' leadership includes:
4D Path has been backed by several prominent investors over the years, including:
Specific high-profile executive new hires or departures at 4D Path within the immediate past 12 months have not been widely publicized in major news outlets. Companies at this stage often manage team transitions internally. Rodrigo Navarro joined as CCO in late 2022, which is slightly outside the 12-month window but a significant recent addition.
Discover the tools 4D Path uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
While not officially published, companies like 4D Path commonly use standardized email formats. Based on industry conventions, the most probable formats are first initial followed by last name, or first name followed by last name, at their domain.
[first_initial][last]@4dpath.com or [first].[last]@4dpath.com
Format
smukhopadhyay@4dpath.com
Example
80%
Success rate
PR Newswire • January 24, 2023
4D Path announced the closing of its Series A financing round, led by ARTIS Ventures with participation from existing investors Vesalius Biocapital III and RealTech Boston, alongside new investors. The funds will be used to accelerate the development and commercialization of its patented AI-driven precision pathology platform....more
Business Wire • May 10, 2022
4D Path and Labcorp (NYSE: LH) announced a collaboration to facilitate access to 4D Path's AI-powered quantitative pathology solution. The collaboration aims to enhance cancer diagnosis and improve patient care by leveraging Labcorp's extensive diagnostic network and 4D Path's innovative technology....more
4D Path News • November 2, 2023
4D Path announced its participation and presentation of new data at the SITC 38th Annual Meeting, highlighting advancements in their AI-driven platform for immuno-oncology applications and biomarker discovery....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including 4D Path, are just a search away.